Pharmacology · Specific antidotes
Flumazenil !
A competitive antagonist at the benzodiazepine site of the GABA-A receptor. It reverses benzodiazepine sedation but can trigger seizures.
Updated 2026-11-01
The figure shows the human α1β2γ2 GABA-A receptor bound to GABA and flumazenil, solved by cryo-electron microscopy.
Mechanism of action
Benzodiazepines bind between the α and γ subunits of the GABA-A receptor and make GABA open the chloride channel more often. Flumazenil occupies that same site without activating it, so it displaces the benzodiazepine and reverses sedation and respiratory depression. It does not reverse ethanol, barbiturates or general anaesthetics, which act at other sites. In a dependent patient it can provoke abrupt withdrawal with seizures.
- Benzodiazepines boost GABA at the α/γ site
- Flumazenil competes for that same site
- Sedation and respiratory depression are reversed
- Short action: sedation may return
Pharmacokinetics
- Distribution
- Distributes quickly outside the blood; about half bound to plasma proteins
- Metabolism
- Liver; clearance falls sharply in liver disease
- Half-life
- About an hour, shorter than most benzodiazepines
- Onset and duration
- Within minutes; each dose takes about 6 to 10 minutes to reach its full effect
Indications
- Reversal of benzodiazepine sedation after procedures or anaesthesia (iatrogenic over-sedation)
- Selected cases of benzodiazepine overdose; it is not used routinely in unknown overdoses in the emergency department
Adverse effects
Common
- Agitation, anxiety and emotional lability
- Nausea and vomiting
- Dizziness
- Pain at the injection site
Contraindications
- A benzodiazepine given to control a life-threatening condition (status epilepticus, raised intracranial pressure)
- Signs of serious tricyclic antidepressant overdose
- Hypersensitivity to flumazenil or benzodiazepines
Key interactions
- Tricyclic antidepressants and other proconvulsant drugs
- Removing the benzodiazepine protection unmasks seizures and arrhythmias
- Long-acting or large doses of benzodiazepines
- They outlast flumazenil, so sedation can return
What is monitored
- Level of consciousness and respiratory rate for a prolonged period after the last dose
- Seizure activity
- ECG, especially if a tricyclic may be involved
Administration and safety
- Given intravenously in small increments, titrated to effect
- Through a freely running infusion in a large vein, to limit pain and irritation
- Airway and ventilation are secured first; it does not replace ventilatory support
Nursing care
- Ask about long-term benzodiazepine use and seizure history before it is given
- Have seizure treatment ready
- Observe for resedation and do not discharge early
Pregnancy and breastfeeding
There are no adequate studies in pregnancy; it is used only when the benefit clearly outweighs the risk.
Test yourself
Think of the answer, then tap the question to see it.
Where does flumazenil bind?
To the benzodiazepine site of the GABA-A receptor, at the α/γ subunit interface, as a competitive antagonist.
Why is flumazenil not used routinely in unknown overdoses?
It can cause seizures in benzodiazepine dependence or when tricyclics or other proconvulsants were also taken.
Why can a patient become sedated again after flumazenil?
Its half-life is about an hour, shorter than that of many benzodiazepines.
Does flumazenil reverse alcohol or barbiturate sedation?
No; those act on other sites of the GABA-A receptor.
Related drugs
← Back to the class: Specific antidotes
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: DailyMed - FLUMAZENIL injection, solution (DailyMed (U.S. National Library of Medicine), 2026); Guía para el Manejo de Emergencias Toxicológicas (Ministerio de Salud y Protección Social; Organización Panamericana de la Salud, 2017); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026); RCSB PDB - 6X3U: Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil (RCSB Protein Data Bank, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.